Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(19 sites)
Argentina
Centro Médico Vitae, Nueve de Julio, Buenos Aires Centro de Investigaciones Clínicas - Instituto de Especialidades de la Salud Rosario, Rosario, Santa Fe Province Centro Respiratorio Infantil, Rosario, Santa Fe Province Fundación CIDEA, Buenos Aires Hospital Italiano de Buenos Aires, Buenos Aires Centro de Educación Medica de Investigaciones Clinicas "Norberto Quirno" (CEMIC), Buenos Aires China
Beijing Tongren Hospital, Beijing, Beijing Municipality The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangzhou The First Affiliated Hospital, Sun Yat-sen University, Zhongshan, Guangzhou The Third Xiangya Hospital of Central South University, Xiangya, Hunan Changzhou Third People's Hospital, Changzhou, Jiangsu The Affiliated Hospital of Qingdao University, Qingdao, Shandong Eye & ENT Hospital of Fudan University, Shanghai, Shanghai Municipality Tongji Hospital Tongji Medical College of HUST, Tongji, Wuhan Union Hospital Tongji Medical College of HUST, Huangzhou Portugal
Unidade de Local de Saúde de Santo António, E.P.E., Porto ULS Lezíria- Hospital Distrital de Santarém, Santarém Spain
Hospital IMED Benidorm, Benidorm, Alicante Hospital General Universitario Dr. Balmis, Alicante